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DISCUSSION
Dr Wesley S. Moore (Los Angeles, Calif). Dr Rockman, that
was an excellent presentation and a very carefully analyzed dataset.
I think it’s going to be extremely helpful to those of us who are
trying to justify carrying out carotid duplex scan screening of
patients who have appropriate risk factors.
This screening program is somewhat reminiscent of screening
for patients with abdominal aortic aneurysm. In those instances,
while the occurrence of small aneurysms, and perhaps small carotid
stenoses, was fairly common, the number of patients who actually
had lesions that were appropriate for surgery was few.
I wonder if you can share with us this morning the percentage
of patients who had lesions perhaps in the 60% to 79%, or perhaps
the 80% to 99% stenosis category, which would have demanded
surgical treatment early on, as opposed to those who have lesions
that will just simply be followed up.
Dr Caron B. Rockman. Thank you for those comments, Dr.
Moore.
I must tell you that unfortunately it’s quite difficult when you
screen patients to obtain ideal follow-up. We make recommenda-
tions to the patients and their primary care practitioners to get a
formal carotid duplex scan, but the patients did not always follow
up with that recommendation.
However, we did get formal duplex scans on nearly 90% of
these patients. We identified one patient with a carotid occlusion.
There were actually no patients in this series who had a severe
stenosis in the 80% to 99% range; we did not stratify in the
moderate range between 50% and 60%, and 60% and 79%.
That could be considered a criticism of our screening in that
we haven’t identified patients who need carotid intervention right
now. But I would counter that by saying that we’re not doing this
to simply identify surgical patients, but to increase overall patient
awareness and national awareness of stroke that there are ways to
prevent strokes from occurring.
Dr John J. Ricotta (Stony Brook, NY). You said there was no
relationship to age. That is not only counterintuitive, but flies in
the face of a lot of other data that suggest that carotid stenosis is
associated with age.
What was the age range of your screening population? Do you
think that you failed to find a correlation because of the age range
of the screening?
Dr Rockman. I think so. I think we really have selected out
our older patients to begin with, and that’s why we didn’t find a
relationship. Our age range was 60 to 90. In our analysis, we
examined age both as a continuous variable with t test analysis as
well as by dividing the patients into two sections based on 80 years
of age. There was still no statistically significant relationship.
Other studies have found a very significant relationship be-
tween age and the prevalence of carotid artery disease. However,
most of those screening studies have screened patients who are
much younger. I believe we probably selected our population to
begin with, and within this particular population there was no
relationship noted.
Dr Ricotta. Well, Nick Kouchoukos’s data actually show over
60, a very nice increase with age. You might want to look at age as
a continuous variable.
Dr John Blebea (Hershey, Pa). I think it is important in
reviewing these data to emphasize that when we, as surgeons, talk
about screening, we are assuming that risk factors exist in the
people who are being examined. We are not screening just anyone
walking in through the door. That is important because others do
not necessarily share that assumption when the term “screening” is
used.
As recently as last week at the American Institute of Ultra-
sound in Medicine annual meeting, the Committee on Standards
reviewed and approved a policy statement concluding that screen-
ing of asymptomatic patients for carotid disease is not justified.
However, it was recognized that people with identified risk factors
are justified in undergoing screening. Therefore studies such as
these are important in identifying and documenting that there are
population factors for carotid disease. When we talk about and
propose screening programs, therefore, we are not talking about
general population screening programs but screening of people
with identified risk factors.
I also have a question to ask you. I recognize the need to
measure the blood pressure in studies such as these, to document
the presence of hypertension. But do you, in fact, need to do that?
If such a screening program is to be instituted more broadly, is a
history alone of hypertension sufficient to define the person to be at
high risk for carotid arterial disease?
Dr Rockman. I think, in answer to your second question, a
history of hypertension alone probably is sufficient. I also think,
frankly, it’s difficult to make a definitive diagnosis of new hyper-
tension based on one blood pressure measurement. It’s true that if
we can eliminate the blood pressure measurement at the screening,
we may be able to further streamline the process.
I also agree completely with your first statement. I think also,
as surgeons, we have to take an overall interest in stroke prevention
and can’t just present to people that we’re just trying to identify
patients to operate on; we need to see this problem as a more global
issue.
Dr William R. Flinn (Baltimore, Md). Dr Rockman, we are
indebted to your group for stimulating this interest in screening for
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vascular disease nationally. Your patient population is very similar to
the population of the AVA national screening program in that it was
more than 60% women. You did not find that carotid stenosis was
more common in men than women in your screening study, which is
unusual, considering our presumption that atherosclerosis is always
more common in men. Is it your feeling that, like heart disease,
vascular disease, and carotid disease specifically, is underdiagnosed
and undertreated, specifically in women, in our population?
Dr Rockman. I think that’s an interesting point. Thank you,
Dr Flinn.
Certainly our screening population is about 65% women. We
can all speculate on what the reasons for this gender distribution
may be. It may have something to do with where the advertise-
ments and the publicity for these screenings are placed.
We did not find gender to be a specific factor for a risk of an
overall positive screening test or of occult carotid artery disease
alone. However, despite traditional demographics that show an
increased risk for atherosclerotic disease in the male population,
there is still a very significant prevalence in women. I believe it’s an
important issue that needs additional attention.
Dr George Lavenson (Visalia, Calif). I’d like to congratulate
Dr Rockman and the NYU group, not only for your presentation
but also for your leadership role in helping to evaluate and to
establish national stroke prevention screening.
In our area, the San Joaquin Valley in Central California,
which is more rural and has a high stroke rate—it’s a stroke
belt—we do find that a significant number of those screened have
carotid stenosis in the 80% to 99% category. And the more rural we
get, the higher the yield. We have had up to 20% to 30% yield with
greater than 50% stenosis. We have had some patients with high-
grade stenosis who during surgery under local anesthesia did not
tolerate occlusion, and surely would have had stroke with any
progression of that nearly completely occluding lesion if it had not
been found and removed.
So I’d really like to congratulate you and ask what your plans
are for further continuance of your stroke screening studies and
further establishment of stroke screening nationally.
Dr Rockman. Thank you, Dr. Lavenson, for those com-
ments, and we appreciate your work in this area.
An additional criticism of our work may be that our popula-
tion is relatively homogeneous with regard to socioeconomic class
and race. We plan to take these screenings out into the community
to have more ethnic and racial diversity and to provide outreach to
socioeconomically disadvantaged populations.
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